102 related articles for article (PubMed ID: 11196836)
1. Solvothermal construction of a coordination polymer around in situ generated pyroglutamic acid: preparation, crystal structure, and magnetic behavior of [Mn(C5H6NO3)2]infinity.
Gutschke SO; Price DJ; Powell AK; Wood PT
Inorg Chem; 2000 Aug, 7; 39(16):3705-7. PubMed ID: 11196836
[No Abstract] [Full Text] [Related]
2. Synthesis of quaternary stereogenic centres via stereoselective intermolecular Friedel-Crafts reactions.
Ball JC; Gleave R; Jones S
Org Biomol Chem; 2011 Jun; 9(11):4353-60. PubMed ID: 21505705
[TBL] [Abstract][Full Text] [Related]
3. Five- and six-membered ring opening of pyroglutamic diketopiperazine.
Parrish DA; Mathias LJ
J Org Chem; 2002 Mar; 67(6):1820-6. PubMed ID: 11895398
[TBL] [Abstract][Full Text] [Related]
4. Expeditious access to unprotected racemic pyroglutamic acids.
Isaacson J; Gilley CB; Kobayashi Y
J Org Chem; 2007 May; 72(10):3913-6. PubMed ID: 17417909
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Access to 3-Substituted Pyroglutamic Acids from Tetramate Derivatives of Serine, Threonine,
Bagum H; Christensen KE; Genov M; Pretsch A; Pretsch D; Moloney MG
J Org Chem; 2019 Aug; 84(16):10257-10279. PubMed ID: 31287955
[TBL] [Abstract][Full Text] [Related]
6. Pseudopeptide foldamers: the homo-oligomers of pyroglutamic acid.
Bernardi F; Garavelli M; Scatizzi M; Tomasini C; Trigari V; Crisma M; Formaggio F; Peggion C; Toniolo C
Chemistry; 2002 Jun; 8(11):2516-25. PubMed ID: 12180330
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of ( 2S, 4S)-4-phenylamino-5-oxoproline derivatives.
Nizova IA; Krasnov VP; Levit GL; Kodess MI
Amino Acids; 2002; 22(2):179-86. PubMed ID: 12395185
[TBL] [Abstract][Full Text] [Related]
8. Origin of diastereoselection in the hydrosilylation of chiral N-acyliminium intermediates derived from pyroglutamic acid.
Oba M; Koguchi S; Nishiyama K; Kaneno D; Tomoda S
Angew Chem Int Ed Engl; 2004 Apr; 43(18):2412-5. PubMed ID: 15114576
[No Abstract] [Full Text] [Related]
9. 1,3-dipolar cycloaddition of furfuryl nitrones with acrylates. A convenient approach to protected 4-hydroxypyroglutamic acids.
Merino P; Anoro S; Franco S; Merchan FL; Tejero T; Tuñon V
J Org Chem; 2000 Mar; 65(5):1590-6. PubMed ID: 10814132
[No Abstract] [Full Text] [Related]
10. Synthesis of cis-4-trifluoromethyl- and cis-4-difluoromethyl-l-pyroglutamic acids.
Qiu XL; Qing FL
J Org Chem; 2003 May; 68(9):3614-7. PubMed ID: 12713369
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective synthesis of conformationally constrained omega-amino acid analogues from pyroglutamic acid.
Bentz EL; Goswami R; Moloney MG; Westaway SM
Org Biomol Chem; 2005 Aug; 3(15):2872-82. PubMed ID: 16032366
[TBL] [Abstract][Full Text] [Related]
12. Massive glutamine cyclization to pyroglutamic acid in human serum discovered using NMR spectroscopy.
Nagana Gowda GA; Gowda YN; Raftery D
Anal Chem; 2015 Apr; 87(7):3800-5. PubMed ID: 25746059
[TBL] [Abstract][Full Text] [Related]
13. [The molecular structure of N-hydroxymethylpyrrolidone carboxylic acid. The structure determination of the reaction product of L-pyroglutamic acid with formaldehyde (author's transl)].
Kanao S; Nagashima N
Yakugaku Zasshi; 1978 Mar; 98(3):293-6. PubMed ID: 565811
[No Abstract] [Full Text] [Related]
14. Effect of chirality on the structural behaviour of hydrogen-bonded n-alkylammonium pyroglutamates in the crystalline and smectic state.
Tsiourvas D; Paleos CM; Skoulios A
Chemistry; 2003 Nov; 9(21):5250-8. PubMed ID: 14613133
[TBL] [Abstract][Full Text] [Related]
15. Uncatalysed diaryldiazo cyclopropanations on bicyclic lactams: access to annulated prolines.
Harris L; Gilpin M; Thompson AL; Cowley AR; Moloney MG
Org Biomol Chem; 2015 Jun; 13(23):6522-50. PubMed ID: 25975925
[TBL] [Abstract][Full Text] [Related]
16. Bispalladacycle-catalyzed Michael addition of in situ formed azlactones to enones.
Weber M; Jautze S; Frey W; Peters R
Chemistry; 2012 Nov; 18(46):14792-804. PubMed ID: 23018882
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of two Bordetella pertussis periplasmic receptors contribute to defining a novel pyroglutamic acid binding DctP subfamily.
Rucktooa P; Antoine R; Herrou J; Huvent I; Locht C; Jacob-Dubuisson F; Villeret V; Bompard C
J Mol Biol; 2007 Jun; 370(1):93-106. PubMed ID: 17499270
[TBL] [Abstract][Full Text] [Related]
18. Spirocyclic systems derived from pyroglutamic acid.
Cowley AR; Hill TJ; Kocis P; Moloney MG; Stevenson RD; Thompson AL
Org Biomol Chem; 2011 Oct; 9(20):7042-56. PubMed ID: 21858317
[TBL] [Abstract][Full Text] [Related]
19. Conformational properties of 2,3-methanopyroglutamic acid in peptides: NMR and x-ray diffraction studies.
Mapelli C; Elrod LF; Switzer FL; Stammer CH; Holt EM
Biopolymers; 1989 Jan; 28(1):123-8. PubMed ID: 2497811
[TBL] [Abstract][Full Text] [Related]
20. Side reactions in the pyroglutamic acid-7-amino-4-methylcoumarin synthesis.
Zicane D; Petrova M; Tetere Z; Kreishman G; Brooks E; Karlson J; Kalejs U
Int J Pept Protein Res; 1996 Jul; 48(1):56-8. PubMed ID: 8844263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
